Regulation and involvement of matrix metalloproteinases in vascular diseases

Area of Science:

• Biochemistry
• Molecular Biology
• Pathology

Background:

• Matrix metalloproteinases (MMPs) are zinc-dependent endopeptidases that degrade extracellular matrix (ECM) proteins.
• Dysregulation of MMPs is associated with various vascular diseases, including hypertension and atherosclerosis.
• MMPs are classified into distinct subgroups based on their substrate specificity and structure.

Purpose of the Study:

• To review recent advances in matrix metalloproteinase (MMP) biology.
• To discuss the involvement of MMPs in the pathogenesis of vascular diseases.
• To highlight the role of MMPs and their inhibitors (TIMPs) in ECM remodeling and disease development.

Main Methods:

• Literature review of recent advances in MMP biology and vascular disease.
• Analysis of MMP classification and regulatory factors.
• Examination of the role of MMP-TIMP imbalance in vascular pathologies.

Main Results:

• MMP production is stimulated by factors like oxidative stress, growth factors, and inflammation, leading to ECM remodeling.
• An imbalance between MMPs and tissue inhibitors of metalloproteinases (TIMPs) is linked to hypertension, atherosclerotic plaque instability, aortic aneurysms, and varicose veins.
• Epigenetic regulation of MMPs is emerging as a factor in angiogenesis and atherosclerosis.

Conclusions:

• Matrix metalloproteinases (MMPs) play a critical role in vascular health and disease.
• Imbalances in MMP and TIMP activity significantly contribute to the development and progression of vascular diseases.
• Pharmacological inhibition of MMPs shows potential for therapeutic intervention in vascular conditions.